Skip to main content
Top
Published in: Journal of Clinical Immunology 8/2020

Open Access 01-11-2020 | Primary Immunodeficiency | Original Article

Heterozygous TLR3 Mutation in Patients with Hantavirus Encephalitis

Authors: Terhi Partanen, Jie Chen, Johanna Lehtonen, Outi Kuismin, Harri Rusanen, Olli Vapalahti, Antti Vaheri, Veli-Jukka Anttila, Michaela Bode, Nina Hautala, Tytti Vuorinen, Virpi Glumoff, Minna Kraatari, Pirjo Åström, Janna Saarela, Heikki Kauma, Lazaro Lorenzo, Jean-Laurent Casanova, Shen-Ying Zhang, Mikko Seppänen, Timo Hautala

Published in: Journal of Clinical Immunology | Issue 8/2020

Login to get access

Abstract

Puumala hantavirus (PUUV) hemorrhagic fever with renal syndrome (HFRS) is common in Northern Europe; this infection is usually self-limited and severe complications are uncommon. PUUV and other hantaviruses, however, can rarely cause encephalitis. The pathogenesis of these rare and severe events is unknown. In this study, we explored the possibility that genetic defects in innate anti-viral immunity, as analogous to Toll-like receptor 3 (TLR3) mutations seen in HSV-1 encephalitis, may explain PUUV encephalitis. We completed exome sequencing of seven adult patients with encephalitis or encephalomyelitis during acute PUUV infection. We found heterozygosity for the TLR3 p.L742F novel variant in two of the seven unrelated patients (29%, p = 0.0195). TLR3-deficient P2.1 fibrosarcoma cell line and SV40-immortalized fibroblasts (SV40-fibroblasts) from patient skin expressing mutant or wild-type TLR3 were tested functionally. The TLR3 p.L742F allele displayed low poly(I:C)-stimulated cytokine induction when expressed in P2.1 cells. SV40-fibroblasts from three healthy controls produced increasing levels of IFN-λ and IL-6 after 24 h of stimulation with increasing concentrations of poly(I:C), whereas the production of the cytokines was impaired in TLR3 L742F/WT patient SV40-fibroblasts. Heterozygous TLR3 mutation may underlie not only HSV-1 encephalitis but also PUUV hantavirus encephalitis. Such possibility should be further explored in encephalitis caused by these and other hantaviruses.
Appendix
Available only for authorised users
Literature
1.
go back to reference Avsic-Zupanc T, Saksida A, Korva M. Hantavirus infections. Clin Microbiol Infect. 2019;21S:e6–e16.CrossRef Avsic-Zupanc T, Saksida A, Korva M. Hantavirus infections. Clin Microbiol Infect. 2019;21S:e6–e16.CrossRef
2.
go back to reference Vaheri A, Henttonen H, Voutilainen L, Mustonen J, Sironen T, Vapalahti O. Hantavirus infections in Europe and their impact on public health. Rev Med Virol. 2013;23:35–49.CrossRef Vaheri A, Henttonen H, Voutilainen L, Mustonen J, Sironen T, Vapalahti O. Hantavirus infections in Europe and their impact on public health. Rev Med Virol. 2013;23:35–49.CrossRef
3.
go back to reference Hautala T, Mähonen SM, Sironen T, Hautala N, Pääkkö E, Karttunen A, et al. Central nervous system-related symptoms and findings are common in acute Puumala hantavirus infection. Ann Med. 2010;42:344–51.CrossRef Hautala T, Mähonen SM, Sironen T, Hautala N, Pääkkö E, Karttunen A, et al. Central nervous system-related symptoms and findings are common in acute Puumala hantavirus infection. Ann Med. 2010;42:344–51.CrossRef
4.
go back to reference Alexeyev OA, Morozov VG. Neurological manifestations of hemorrhagic fever with renal syndrome caused by Puumala virus: review of 811 cases. Clin Infect Dis. 1995;20:255–8.CrossRef Alexeyev OA, Morozov VG. Neurological manifestations of hemorrhagic fever with renal syndrome caused by Puumala virus: review of 811 cases. Clin Infect Dis. 1995;20:255–8.CrossRef
5.
go back to reference Hautala T, Sironen T, Vapalahti O, Pääkko E, Särkioja T, Salmela PI, et al. Hypophyseal hemorrhage and panhypopituitarism during Puumala virus infection: magnetic resonance imaging and detection of viral antigen in the hypophysis. Clin Infect Dis. 2002;35:96–101.CrossRef Hautala T, Sironen T, Vapalahti O, Pääkko E, Särkioja T, Salmela PI, et al. Hypophyseal hemorrhage and panhypopituitarism during Puumala virus infection: magnetic resonance imaging and detection of viral antigen in the hypophysis. Clin Infect Dis. 2002;35:96–101.CrossRef
6.
go back to reference Pekic S, Cvijovic G, Stojanovic M, Kendereski A, Micic D, Popovic V. Hypopituitarism as a late complication of hemorrhagic fever. Endocrine. 2005;26:79–82.CrossRef Pekic S, Cvijovic G, Stojanovic M, Kendereski A, Micic D, Popovic V. Hypopituitarism as a late complication of hemorrhagic fever. Endocrine. 2005;26:79–82.CrossRef
7.
go back to reference Stojanovic M, Pekic S, Cvijovic G, Miljic D, Doknic M, Nikolic-Djurovic M, et al. High risk of hypopituitarism in patients who recovered from hemorrhagic fever with renal syndrome. J Clin Endocrinol Metab. 2008;93:2722–8.CrossRef Stojanovic M, Pekic S, Cvijovic G, Miljic D, Doknic M, Nikolic-Djurovic M, et al. High risk of hypopituitarism in patients who recovered from hemorrhagic fever with renal syndrome. J Clin Endocrinol Metab. 2008;93:2722–8.CrossRef
8.
go back to reference Venkatesan A, Tunkel AR, Bloch KC, Lauring AS, Sejvar J, Bitnun A, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013;57:1114–28.CrossRef Venkatesan A, Tunkel AR, Bloch KC, Lauring AS, Sejvar J, Bitnun A, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013;57:1114–28.CrossRef
9.
go back to reference Bergmann F, Krone B, Bleich S, Prange H, Paulus W. Encephalitis due to a hantavirus infection. J Inf Secur. 2002;45:58–9. Bergmann F, Krone B, Bleich S, Prange H, Paulus W. Encephalitis due to a hantavirus infection. J Inf Secur. 2002;45:58–9.
10.
go back to reference Krause R, Aberle S, Haberl R, Daxbock F, Wenisch C. Puumala virus infection with acute disseminated encephalomyelitis and multiorgan failure. Emerg Infect Dis. 2003;9:603–5.CrossRef Krause R, Aberle S, Haberl R, Daxbock F, Wenisch C. Puumala virus infection with acute disseminated encephalomyelitis and multiorgan failure. Emerg Infect Dis. 2003;9:603–5.CrossRef
11.
go back to reference Mähönen SM, Sironen T, Vapalahti O, Pääkkö E, Hautala N, Ilonen J, et al. Puumala virus RNA in cerebrospinal fluid in a patient with uncomplicated nephropathia epidemica. J Clin Virol. 2007;40:248–51.CrossRef Mähönen SM, Sironen T, Vapalahti O, Pääkkö E, Hautala N, Ilonen J, et al. Puumala virus RNA in cerebrospinal fluid in a patient with uncomplicated nephropathia epidemica. J Clin Virol. 2007;40:248–51.CrossRef
12.
go back to reference Cerar D, vsic-Zupanc T, Jereb M, Strle F. Case report: severe neurological manifestation of Dobrava hantavirus infection. J Med Virol. 2007;79:1841–3.CrossRef Cerar D, vsic-Zupanc T, Jereb M, Strle F. Case report: severe neurological manifestation of Dobrava hantavirus infection. J Med Virol. 2007;79:1841–3.CrossRef
13.
go back to reference Huisa BN, Chapin JE, Adair JC. Central nervous system complications following Hanta virus cardiopulmonary syndrome. J Neuro-Oncol. 2009;15:202–5. Huisa BN, Chapin JE, Adair JC. Central nervous system complications following Hanta virus cardiopulmonary syndrome. J Neuro-Oncol. 2009;15:202–5.
14.
go back to reference Talamonti L, Padula PJ, Canteli MS, Posner F, Marczeski FP, Weller C. Hantavirus pulmonary syndrome: encephalitis caused by virus Andes. J Neuro-Oncol. 2011;17:189–92. Talamonti L, Padula PJ, Canteli MS, Posner F, Marczeski FP, Weller C. Hantavirus pulmonary syndrome: encephalitis caused by virus Andes. J Neuro-Oncol. 2011;17:189–92.
15.
go back to reference Fernando R, Capone D, Elrich S, Mantovani R, Quarles L III, D'Amato A, et al. Infection with New York orthohantavirus and associated respiratory failure and multiple cerebral complications. Emerg Infect Dis. 2019;25:1241–3.CrossRef Fernando R, Capone D, Elrich S, Mantovani R, Quarles L III, D'Amato A, et al. Infection with New York orthohantavirus and associated respiratory failure and multiple cerebral complications. Emerg Infect Dis. 2019;25:1241–3.CrossRef
16.
go back to reference Hautala T, Hautala N, Mähonen SM, Sironen T, Pääkko E, Karttunen A, et al. Young male patients are at elevated risk of developing serious central nervous system complications during acute Puumala hantavirus infection. BMC Infect Dis. 2011;11:217.CrossRef Hautala T, Hautala N, Mähonen SM, Sironen T, Pääkko E, Karttunen A, et al. Young male patients are at elevated risk of developing serious central nervous system complications during acute Puumala hantavirus infection. BMC Infect Dis. 2011;11:217.CrossRef
17.
go back to reference Lim HK, Seppänen M, Hautala T, Ciancanelli MJ, Itan Y, Lafaille FG, et al. TLR3 deficiency in herpes simplex encephalitis: high allelic heterogeneity and recurrence risk. Neurology. 2014;83:1888–97.CrossRef Lim HK, Seppänen M, Hautala T, Ciancanelli MJ, Itan Y, Lafaille FG, et al. TLR3 deficiency in herpes simplex encephalitis: high allelic heterogeneity and recurrence risk. Neurology. 2014;83:1888–97.CrossRef
18.
go back to reference Lim HK, Huang SXL, Chen J, Kerner G, Gilliaux O, Bastard P, et al. Severe influenza pneumonitis in children with inherited TLR3 deficiency. J Exp Med. 2019;216:2038–56.CrossRef Lim HK, Huang SXL, Chen J, Kerner G, Gilliaux O, Bastard P, et al. Severe influenza pneumonitis in children with inherited TLR3 deficiency. J Exp Med. 2019;216:2038–56.CrossRef
19.
go back to reference Sironi M, Peri AM, Cagliani R, Forni D, Riva S, Biasin M, et al. TLR3 mutations in adult patients with herpes simplex virus and varicella-zoster virus encephalitis. J Infect Dis. 2017;215:1430–4.CrossRef Sironi M, Peri AM, Cagliani R, Forni D, Riva S, Biasin M, et al. TLR3 mutations in adult patients with herpes simplex virus and varicella-zoster virus encephalitis. J Infect Dis. 2017;215:1430–4.CrossRef
20.
go back to reference Zhang SY, Herman M, Ciancanelli MJ, de Perez DR, Sancho-Shimizu V, Abel L, et al. TLR3 immunity to infection in mice and humans. Curr Opin Immunol. 2013;25:19–33.CrossRef Zhang SY, Herman M, Ciancanelli MJ, de Perez DR, Sancho-Shimizu V, Abel L, et al. TLR3 immunity to infection in mice and humans. Curr Opin Immunol. 2013;25:19–33.CrossRef
21.
go back to reference Sulonen AM, Ellonen P, Almusa H, Lepistö M, Eldfors S, Hannula S, et al. Comparison of solution-based exome capture methods for next generation sequencing. Genome Biol. 2011;12:R94.CrossRef Sulonen AM, Ellonen P, Almusa H, Lepistö M, Eldfors S, Hannula S, et al. Comparison of solution-based exome capture methods for next generation sequencing. Genome Biol. 2011;12:R94.CrossRef
22.
go back to reference Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet. 2016;99:877–85.CrossRef Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet. 2016;99:877–85.CrossRef
23.
go back to reference Li Q, Wang K. InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines. Am J Hum Genet. 2017;100:267–80.CrossRef Li Q, Wang K. InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines. Am J Hum Genet. 2017;100:267–80.CrossRef
24.
go back to reference Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47:D886–94.CrossRef Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47:D886–94.CrossRef
25.
go back to reference Davydov EV, Goode DL, Sirota M, Cooper GM, Sidow A, Batzoglou S. Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput Biol. 2010;6:e1001025.CrossRef Davydov EV, Goode DL, Sirota M, Cooper GM, Sidow A, Batzoglou S. Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput Biol. 2010;6:e1001025.CrossRef
26.
go back to reference Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science. 2007;317:1522–7.CrossRef Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science. 2007;317:1522–7.CrossRef
27.
go back to reference Ranjith-Kumar CT, Miller W, Sun J, Xiong J, Santos J, Yarbrough I, et al. Effects of single nucleotide polymorphisms on Toll-like receptor 3 activity and expression in cultured cells. J Biol Chem. 2007;282:17696–705.CrossRef Ranjith-Kumar CT, Miller W, Sun J, Xiong J, Santos J, Yarbrough I, et al. Effects of single nucleotide polymorphisms on Toll-like receptor 3 activity and expression in cultured cells. J Biol Chem. 2007;282:17696–705.CrossRef
28.
go back to reference Willmann O, Ahmad-Nejad P, Neumaier M, Hennerici MG, Fatar M. Toll-like receptor 3 immune deficiency may be causative for HSV-2-associated mollaret meningitis. Eur Neurol. 2010;63:249–51.CrossRef Willmann O, Ahmad-Nejad P, Neumaier M, Hennerici MG, Fatar M. Toll-like receptor 3 immune deficiency may be causative for HSV-2-associated mollaret meningitis. Eur Neurol. 2010;63:249–51.CrossRef
29.
go back to reference Yang CA, Raftery MJ, Hamann L, Guerreiro M, Grutz G, Haase D, et al. Association of TLR3-hyporesponsiveness and functional TLR3 L412F polymorphism with recurrent herpes labialis. Hum Immunol. 2012;73:844–51.CrossRef Yang CA, Raftery MJ, Hamann L, Guerreiro M, Grutz G, Haase D, et al. Association of TLR3-hyporesponsiveness and functional TLR3 L412F polymorphism with recurrent herpes labialis. Hum Immunol. 2012;73:844–51.CrossRef
30.
go back to reference Cooke G, Kamal I, Strengert M, Hams E, Mawhinney L, Tynan A, et al. Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis. QJM. 2018;111:217–24.CrossRef Cooke G, Kamal I, Strengert M, Hams E, Mawhinney L, Tynan A, et al. Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis. QJM. 2018;111:217–24.CrossRef
31.
go back to reference Gosu V, Son S, Shin D, Song KD. Insights into the dynamic nature of the dsRNA-bound TLR3 complex. Sci Rep. 2019;9:3652.CrossRef Gosu V, Son S, Shin D, Song KD. Insights into the dynamic nature of the dsRNA-bound TLR3 complex. Sci Rep. 2019;9:3652.CrossRef
32.
go back to reference Sun Y, Leaman DW. Ectopic expression of toll-like receptor-3 (TLR-3) overcomes the double-stranded RNA (dsRNA) signaling defects of P2.1 cells. J Interferon Cytokine Res. 2004;24:350–61.CrossRef Sun Y, Leaman DW. Ectopic expression of toll-like receptor-3 (TLR-3) overcomes the double-stranded RNA (dsRNA) signaling defects of P2.1 cells. J Interferon Cytokine Res. 2004;24:350–61.CrossRef
33.
go back to reference Guo Y, Audry M, Ciancanelli M, Alsina L, Azevedo J, Herman M, et al. Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J Exp Med. 2011;208:2083–98.CrossRef Guo Y, Audry M, Ciancanelli M, Alsina L, Azevedo J, Herman M, et al. Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J Exp Med. 2011;208:2083–98.CrossRef
34.
go back to reference Handke W, Oelschlegel R, Franke R, Kruger DH. Rang A Hantaan virus triggers TLR3-dependent innate immune responses. J Immunol. 2009;182:2849–58.CrossRef Handke W, Oelschlegel R, Franke R, Kruger DH. Rang A Hantaan virus triggers TLR3-dependent innate immune responses. J Immunol. 2009;182:2849–58.CrossRef
35.
go back to reference Zhang Y, Liu B, Ma Y, Yi J, Zhang C, Zhang Y, et al. Hantaan virus infection induces CXCL10 expression through TLR3, RIG-I, and MDA-5 pathways correlated with the disease severity. Mediat Inflamm. 2014;2014:697837. Zhang Y, Liu B, Ma Y, Yi J, Zhang C, Zhang Y, et al. Hantaan virus infection induces CXCL10 expression through TLR3, RIG-I, and MDA-5 pathways correlated with the disease severity. Mediat Inflamm. 2014;2014:697837.
36.
go back to reference Meyts I, Bosch B, Bolze A, Boisson B, Itan Y, Belkadi A, et al. Exome and genome sequencing for inborn errors of immunity. J Allergy Clin Immunol. 2016;138:957–69.CrossRef Meyts I, Bosch B, Bolze A, Boisson B, Itan Y, Belkadi A, et al. Exome and genome sequencing for inborn errors of immunity. J Allergy Clin Immunol. 2016;138:957–69.CrossRef
37.
go back to reference Resman RK, Korva M, Bogovic P, Pal E, Strle F, Avsic-Zupanc T. Delayed interferon type 1-induced antiviral state is a potential factor for hemorrhagic fever with renal syndrome severity. J Infect Dis. 2018;217:926–32.CrossRef Resman RK, Korva M, Bogovic P, Pal E, Strle F, Avsic-Zupanc T. Delayed interferon type 1-induced antiviral state is a potential factor for hemorrhagic fever with renal syndrome severity. J Infect Dis. 2018;217:926–32.CrossRef
Metadata
Title
Heterozygous TLR3 Mutation in Patients with Hantavirus Encephalitis
Authors
Terhi Partanen
Jie Chen
Johanna Lehtonen
Outi Kuismin
Harri Rusanen
Olli Vapalahti
Antti Vaheri
Veli-Jukka Anttila
Michaela Bode
Nina Hautala
Tytti Vuorinen
Virpi Glumoff
Minna Kraatari
Pirjo Åström
Janna Saarela
Heikki Kauma
Lazaro Lorenzo
Jean-Laurent Casanova
Shen-Ying Zhang
Mikko Seppänen
Timo Hautala
Publication date
01-11-2020
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 8/2020
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-020-00834-2

Other articles of this Issue 8/2020

Journal of Clinical Immunology 8/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine